Table 1. Relationships of clinical characteristics with the COA-NLR in individuals with NSCLC.
| Variables | COA-NLR 0 (n=149) | COA-NLR 1 (n=108) | COA-NLR 2 (n=36) | P value |
|---|---|---|---|---|
| Age, years | ||||
| >65 | 31 | 34 | 12 | 0.094 |
| <65 | 118 | 74 | 24 | |
| Gender | ||||
| Male | 82 | 88 | 34 | <0.001 |
| Female | 67 | 20 | 2 | |
| Adjuvant therapy | ||||
| None | 32 | 23 | 8 | 0.993 |
| Chemo-radiotherapy | 117 | 85 | 28 | |
| Tobacco | ||||
| Yes | 51 | 62 | 20 | <0.001 |
| No | 98 | 46 | 16 | |
| GPS | ||||
| 0 | 94 | 39 | 0 | <0.001 |
| 1 | 55 | 63 | 12 | |
| 2 | 0 | 6 | 24 | |
| Pathologic N stage | ||||
| N0 | 110 | 74 | 24 | 0.541 |
| N1–N3 | 39 | 34 | 12 | |
| Pathologic T stage | ||||
| T1–T2 | 77 | 27 | 3 | <0.001 |
| T3–T4 | 72 | 81 | 33 | |
| Metastasis | ||||
| No | 141 | 103 | 35 | 0.784 |
| Yes | 8 | 5 | 1 | |
| TNM status | ||||
| I | 81 | 42 | 9 | 0.013 |
| II | 28 | 35 | 13 | |
| III | 32 | 13 | 13 | |
| IV | 8 | 76 | 1 |
COA-NLR, combination of albumin concentration and neutrophil-to-lymphocyte ratio; NSCLC, non-small cell lung cancer; GPS, Glasgow prognostic score; TNM, tumor-node-metastasis.